ClinicalTrials.gov
public full text
Public Domain
Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.
Type 2 DM is due to insulin resistance or low insulin secretion or sometimes a combination of both. Nanotechnology structured water is a type of water that is produced using energy field modulators to change the biological, chemical, and physical properties of water molecules and improve the bioavailability of this nano-water. Objective: To find out the effect of drinking nanotechnology structured water (Magnalife®) on the blood glucose levels in patients with type 2 diabetes mellitus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Smart nanomaterials enabling drug delivery and glucose monitoring for diabetes management.#145883
- Green Digital Diabetes Waste Project#904070
- Device for drug delivery — Roche Diabetes Care, Inc. (US11090427B2)#607365
- Device for drug delivery — Roche Diabetes Care, Inc. (US10272199B2)#607358
- Intelligent and Recognitive Nanoscale Systems for New Therapeutic Applications#957358
Record · ID 1308993
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive